AML-256 A Phase 1 Study of Gilteritinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Final Study Results
Keith W. Pratz, Mohamad Cherry, Nikolai A. Podoltsev, Jessica K. Altman, Alexander E. Perl, Brenda W. Cooper, Joseph G. Jurcic, Tara L. Lin, Gary J. Schiller, Ruishan Wu, Jason E. Hill, Stanley C. Gill, Angela James, Elizabeth Shima Rich, Nahla Hasabou, Mark J. Levis
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'AML-256 A Phase 1 Study of Gilteritinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Final Study Results'. Together they form a unique fingerprint.